Very-Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency in Mice
- 5 September 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 93 (5) , 448-455
- https://doi.org/10.1161/01.res.0000088786.19197.e4
Abstract
Fatty acid oxidation (FAO) defects are inborn errors of metabolism clinically associated with cardiomyopathy and sudden infant death syndrome (SIDS). FAO disorders often present in infancy with myocardial dysfunction and arrhythmias after exposure to stresses such as fasting, exercise, or intercurrent viral illness. It is uncertain whether the heart, in the absence of stress, is normal. We generated very-long-chain acyl-coenzyme A dehydrogenase (VLCAD)-deficient mice by homologous recombination to define the onset and molecular mechanism of myocardial disease. We found that VLCAD-deficient hearts have microvesicular lipid accumulation, marked mitochondrial proliferation, and demonstrated facilitated induction of polymorphic ventricular tachycardia, without antecedent stress. The expression of acyl-CoA synthase (ACS1), adipophilin, activator protein 2, cytochrome c, and the peroxisome proliferator activated receptor γ coactivator-1 were increased immediately after birth, preceding overt histological lipidosis, whereas ACS1 expression was markedly downregulated in the adult heart. We conclude that mice with VLCAD deficiency have altered expression of a variety of genes in the fatty acid metabolic pathway from birth, reflecting metabolic feedback circuits, with progression to ultrastructural and physiological correlates of the associated human disease in the absence of stress.Keywords
This publication has 23 references indexed in Scilit:
- Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouseHuman Molecular Genetics, 2001
- Peroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesisJournal of Clinical Investigation, 2000
- Characterization of the Human Very-Long-Chain Acyl-CoA Dehydrogenase Gene Promoter Region: A Role for Activator Protein 2Molecular Genetics and Metabolism, 1999
- Identification of Two Novel Mutations in the Hypoglycemic Phenotype of Very Long Chain Acyl-CoA Dehydrogenase DeficiencyBiochemical and Biophysical Research Communications, 1999
- Clear Correlation of Genotype with Disease Phenotype in Very–Long-Chain Acyl-CoA Dehydrogenase DeficiencyAmerican Journal of Human Genetics, 1999
- Very long chain acyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid oxidation in fibroblastsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1993
- Fatty acid oxidation disorders: A new class of metabolic diseasesThe Journal of Pediatrics, 1992
- Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vectorNature, 1986
- Influence of site of stimulation on measurement of ventricular vulnerability in the normal and ischemic feline heartThe American Journal of Cardiology, 1984
- Nonsustained polymorphic ventricular tachycardia induced by electrical stimulation in 3 week old canine myocardial infarctionThe American Journal of Cardiology, 1981